Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07565766
PHASE4

Effect of Benzydamine Hydrochloride Mouthrinse on Plaque Accumulation in Periodontally Healthy Female Subjects

Sponsor: University of Zagreb

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to evaluate the effect of a mouthrinse containing an active ingredient benzydamine hydrochloride in the absence of daily oral hygiene. The study includes periodontally healthy female subjects and experimental phase will last for three days. Plaque accumulation is the primary evaluated outcome, measured by a particular periodontal index called Plaque Control Record (PCR). Gingival inflammation (bleeding) is the secondary evaluated outcome, measured by a particular periodontal index called Bleeding on Probing (BoP). Researchers will compare benzyadamine hydrochloride mouthrinse to a placebo (a look-alike substance that contains no active ingredient) mouthwash to see whether benzydamine hydrochloride use results in greater plaque accumulation.

Official title: Effect of Benzydamine Hydrochloride During Short-term Restricted Oral Hygiene: a Randomized, Placebo-controlled Trial

Key Details

Gender

FEMALE

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2013-02

Completion Date

2013-05

Last Updated

2026-05-04

Healthy Volunteers

Yes

Interventions

DRUG

Benzydamine hydrochloride mouthrinse

Participants assigned to the intervention arm will use a mouthrinse containing benzydamine hydrochloride twice daily. A volume of 15 mL will be used per rinse, following a standardized rinsing duration in accordance with the manufacturer's instructions. During the 3-day experimental period, participants will refrain from all mechanical oral hygiene measures to allow assessment of the chemical effects of the mouthrinse on plaque accumulation and gingival inflammation.

OTHER

Placebo mouthrinse

Participants assigned to the placebo arm will use a mouthrinse without active pharmacological ingredients, formulated to match the test product in color, taste, and packaging to ensure blinding. The mouthrinse will be used twice daily in a volume of 15 mL, following a standardized rinsing duration in accordance with the manufacturer's instructions. Mechanical oral hygiene measures will be suspended throughout the 3-day experimental period.

Locations (1)

School of Dental Medicine, University of Zagreb

Zagreb, Croatia